PosterHIVViral Hepatitis and Liver DiseaseAPACC 2020Pooled Analysis of the Efficacy, Safety, and Health Outcomes Following 48 Weeks of Long-acting Cabotegravir and Rilpivirine Maintenance Therapy for HIV-1 Infection in Phase 3 ATLAS and FLAIR Studies: Sub-Analysis in Asian PopulationsView Poster
PosterHIVViral Hepatitis and Liver DiseaseAPACC 2020Treatment Persistence Among HIV-1 Patients Initiating Antiretroviral Therapy in JapanView Poster
PosterHIVViral Hepatitis and Liver DiseaseAPACC 2020Assessment of the Safety of Dolutegravir in HIV-Infected Patients From China: A Real-World, Open-Label, Multicenter, Post-Marketing Surveillance StudyView Poster
PosterHIVViral Hepatitis and Liver DiseaseAPACC 2020Efficacy and Safety of Switching to B/F/TAF in Virologically Suppressed Asian Women Living With HIVView Poster
PosterHIVViral Hepatitis and Liver DiseaseAPACC 2020Efficacy and Safety of Switching to B/F/TAF in Virologically Suppressed Asian Adults Living With HIVView Poster
PosterHIVViral Hepatitis and Liver DiseaseAPACC 2020Durable Efficacy of Dolutegravir (DTG) Plus Lamivudine (3TC) in Antiretroviral Treatment–Naive Adults With HIV-1 Infection: 96-Week Results From the Gemini Studies in Participants From Asian CentresView Poster
PosterHIVViral Hepatitis and Liver DiseaseAPACC 2020Drug Resistance to Novel Non-Nucleoside Reverse Transcriptase Inhibitor Elsulfavirine Among Treatment-Naïve, HIV-Infected Caucasian and Asian PatientsView Poster
AbstractHIVViral Hepatitis and Liver DiseaseAPACC 2020Compliance to Hepatitis B Vaccination Guidelines and Development of Seroprotection in Filipino Hepatitis B Susceptible HIV Patients in a Tertiary Hospital Treatment HUBView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseAPACC 2020Screening and treatment of latent tuberculosis infection among people living with HIV in the era of antiretroviral therapy scale-upView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseAPACC 2020Retention in the HCV Care Cascade for People living with HIV in Delhi and Manipur, India and Malaysia: The HEAD-Start ProjectView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseAPACC 2020Change of seroconversion rate after vaccination with Aimmugen® among MSM.View Abstract
AbstractHIVViral Hepatitis and Liver DiseaseAPACC 2020The Clinical Presentation and Factors Associated with Mortality of HIV-infected patients with neurologic manifestation in Indonesia: a prospective studyView Abstract
